id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1981-N-0012-0031,FDA,FDA-1981-N-0012,FDA/CDER to Arnold & Porter,Other,LET-Letter,2006-10-03T04:00:00Z,2006,10,,,2008-05-30T22:52:38Z,,0,0,09000064805aea87
FDA-1981-N-0012-0030,FDA,FDA-1981-N-0012,HFA-305 to Wyeth,Other,ACK-Acknowledgement Letter,2006-03-30T05:00:00Z,2006,3,,,2008-05-30T22:52:55Z,,0,0,09000064805ae981
FDA-1981-N-0012-0029,FDA,FDA-1981-N-0012,FDA,Notice,NPR-Notice of Proposed Rule-Making,2006-01-25T05:00:00Z,2006,1,2005-12-21T05:00:00Z,2006-03-23T04:59:59Z,2008-05-30T22:52:38Z,,0,0,09000064805ae8fc